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Abstract
Left ventricular hypertrophy (LVH) is usually accompanied by intensive interstitial and perivascular fibrosis, which may
contribute to arrhythmogenic sudden cardiac death. The mechanisms underlying the development of cardiac fibrosis are
incompletely understood. To investigate the role of perivascular inflammation in coronary artery remodeling and cardiac
fibrosis during hypertrophic ventricular remodeling, we used a well-established mouse model of LVH (transverse aortic
constriction [TAC]). Three days after pressure overload, macrophages and T lymphocytes accumulated around and along left
coronary arteries in association with luminal platelet deposition. Consistent with these histological findings, cardiac
expression of IL-10 was upregulated and in the systemic circulation, platelet white blood cell aggregates tended to be
higher in TAC animals compared to sham controls. Since platelets can dynamically modulate perivascular inflammation, we
investigated the impact of thrombocytopenia on the response to TAC. Immunodepletion of platelets decreased early
perivascular T lymphocytes’ accumulation and altered subsequent coronary artery remodeling. The contribution of
lymphocytes were examined in Rag12/2 mice, which displayed significantly more intimal hyperplasia and perivascular
fibrosis compared to wild-type mice following TAC. Collectively, our studies support a role of early perivascular
accumulation of platelets and T lymphocytes in pressure overload-induced inflammation.
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Introduction
Left ventricular hypertrophy (LVH) is a common risk factor for
the development of heart failure and an independent predictor of
cardiovascular death. LVH usually develops in the setting of
mechanical stress, overactive sympathetic drive, or as a conse-
quence of genetic abnormalities. One important pathophysiologic
characteristic of hypertensive LV remodeling is the production of
excessive interstitial fibrillar collagen by fibroblasts [1]. Extensive
fibrosis is thought to impair normal LV diastolic function and
oxygen diffusion, leading to LV dysfunction [2]. Recent clinical
studies have found a strong correlation between potentially fatal
ventricular arrhythmias and myocardial fibrosis, as detected by
delayed hyper-enhancement magnetic resonance imaging in
patients with hypertrophic cardiomyopathy [3]. In addition to
interstitial fibrosis, perivascular fibrosis occurs in the setting of
LVH and congestive heart failure (CHF). LVH also results in
susceptibility to myocardial hypoperfusion and ischemia as a result
of disturbances in coronary flow physiology, that likely reflects
remodeling of coronary arteries [4–9].
Perivascular inflammation has been observed in hypertensive
disease and CHF and may initiate fibrosis and coronary artery
remodeling. Inhibition of inflammatory responses tends to
attenuate cardiac fibrosis in experimental models [10–13]. In
DOCA/salt-induced hypertensive rats, pharmacological targeting
of monocyte/macrophage accumulation ameliorated cardiac
perivascular and interstitial fibrosis and reduced inflammatory
marker expression, such as interleukin 6 (IL6) and monocyte
chemotactic protein-1 (MCP-1) [10–14]. In a rat model of
suprarenal aortic constriction, antibody blockade of either
intercellular adhesion molecule-1 (ICAM-1) or MCP-1 reduced
early macrophage recruitment, and prevented the development of
myocardial fibrosis [12,13]. However, the triggers for initiation of
perivascular inflammation in the setting of LVH are poorly
understood.
Accumulating evidence implicates platelets in vascular inflam-
mation in a variety of settings. Platelets, small cytoplasmic bodies
that lack nuclei, are generated by megakaryocytes in bone
marrow. In settings of vascular injury or inflammation, platelets
adhere to the subendothelial matrix or endothelial cells. Subse-
quent platelet activation maintains hemostasis through platelet to
platelet interactions that form the primary platelet clot. Activated
platelets express and release granule contents. Activation-depen-
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dent surface expression of adhesive molecules such as P-selectin,
serve to recruit leukocytes; inflammatory mediators released by
platelets may modulate leukocyte responses at sites of vascular
injury [15–20]. Thus, in addition to their essential role in
hemostasis, platelets have been proposed to serve as important
mediators of vascular inflammation [15,20–26].
We previously reported that pressure overload in mice created
by transverse aortic constriction (TAC) is associated with a marked
perivascular inflammation, reactive myocardial fibrosis, and
medial thickening of intramyocardial coronary arteries [27]. We
and others have observed a reduction in coronary artery flow
reserve (CFR) following TAC [28–30], raising the possibility that
acute perivascular inflammation plays a role in intramyocardial
artery remodeling during LVH. In this report, we investigated
early cellular events that mediate perivascular inflammation and
coronary artery remodeling. We report that platelets and T
lymphocytes are recruited to coronary arteries after TAC, and that
both cell types may play a role in modulating perivascular
inflammation and fibrosis in the setting of LV pressure overload.
Materials and Methods
Animals
All procedures conformed to the recommendations of ‘‘Guide
for the Care and Use of Laboratory Animals’’ (Department of
Health, Education, and Welfare publication number NIH 78-23,
1996), and were approved by the Institutional Animal Care and
Use Committees at the University of Kentucky. The C57BL/6J
(B6), RAG-1-deficient (Rag12/2) mice, and IL-10-deficient (IL-
102/2) mice, were obtained from The Jackson Laboratory (Bar
Harbor, ME). All the mice were maintained on the C57BL/6J
background.
Transverse aortic constriction model
Pressure overload of the LV was elicited by TAC in male mice
at the age of eight to 12 weeks. Sham surgery, in which a suture
was passed around the aorta but removed without tying, was
performed as a control [27]. Mice were sacrificed at early (one
day, three days, and seven days) and late (five weeks) time points
after surgery. Left ventricle function and coronary flow reserve
were measured by echocardiography and Doppler (Figure 1).
Doppler studies
Velocity of blood flow in the left and right carotid arteries and
coronary artery was measured as described previously [29,30]
using a hand-held 20 MHz Doppler probe (Indus Instruments,
Houston, TX) before and after surgery, as well as at additional
time points post-surgery. The mice were anesthetized with
isoflurane 1.5–2%, and taped supine to a temperature-controlled
board. The board included electrocardiographic electrodes placed
under each limb and a heating pad under the body. Body hair was
clipped and the skin was moistened with water to improve sound
transmission. The Doppler probe was placed on the left and right
sides of the neck at a 45u angle to detect flow velocity in the left
and right carotid arteries. For coronary flow, the probe tip was
placed on the left chest at the level of the cardiac base and pointed
horizontally toward the anterior basal surface of the heart to sense
blood-flow velocity. The optimal Doppler flow velocity signals
were obtained by adjusting the position of the probe and the
Doppler range gate depth of 2 mm (for carotid artery), or 2.5–
3 mm (for coronary artery), to obtain a maximal velocity signal. A
computer-based Doppler signal processor (Model DSPW, Indus
Instruments) was used to store the Doppler signals and for later
analysis. For left coronary artery flow the baseline flow velocity
was recorded at 1% isoflurane concentration. The hyperemic flow
velocity was recorded during maximal vasodilatation induced by
2.5% isoflurane and after three minutes of isoflurane inhalation.
Coronary artery flow reserve was calculated as the ratio of
hyperemic peak flow velocity to baseline peak flow velocity.
Echocardiography
Two-dimensional short- and long-axis views of the left ventricle
were obtained by transthoracic echocardiography performed five
weeks post-TAC using a 45 M-Hz probe (77B) and the Vevo 770
Imaging System (VisualSonics, Toronto, Canada), under 1.5%
isoflurane inhalation as previously described [1]. M-mode tracings
were recorded and used to determine LV-end diastolic diameter
(LVEDD), LV-end systolic diameter (LVESD), and LV-posterior
wall thickness in diastole (LVPWThD), over three cardiac cycles.
Left ventricular fractional shortening (FS) was calculated using the
formula % FS= (LVEDD2LVESD)/LVEDD.
Histology
Mice were weighed and hearts, lungs, livers and kidneys were
dissected at days one, three, seven and five weeks post-surgery.
Hearts were harvested, washed in PBS, and sectioned at the level
of the papillary muscle. The base of the heart was immersed in 4%
PFA for 24 hours, subsequently transferred to 70% ethanol, and
embedded in paraffin. Multiple serial 5 mm sections (six – 10) were
taken every 250 mm from the distal region of the heart up the base
to the aorta. Slides (six – 10) were created that contain two sections
every 250 mm spanning the base of the heart. Slides from each
heart were stained with hematoxylin and eosin, Masson’s
Trichrome and picrosirius red staining. The remaining slides
were archived for later use.
Paraffin-embedded immunohistochemistry (IHC) was done with
a mouse-on-mouse smooth muscle cell actin-a antibody (Sigma A-
5691). In brief, heart sections were first de-paraffinized and placed
in diluted antigen unmasking solution (Vector, Burlingame, CA)
for antigen retrieval using a decloaking chamber (Biocare Medical,
Concord, CA). Non-specific sites were blocked using mouse-on-
mouse IgG blocking reagent (Vector Labs) for one hour at room
temperature (RT). Slides were then incubated with primary
antibody for one hour at RT, followed by 30 minutes with
substrate solution (Vector Red substrate). CAT Hematoxylin
(Biocare Medical) was used for counter-staining. Finally, slides
were dehydrated, mounted with DPX coverslip (Gallard Schle-
singer Industries, Garden City, NY) and covered by cover glasses.
Positive staining was quantified using Metamorph software.
Immunohistochemistry was performed on frozen sections using
CD90.2 (1:100, BD PharmingenTM, San Diego, CA), CD68
(1:200, Serotec, Raleigh, NC), VCAM-1(1:50, BD Pharmin-
genTM), PECAM-1(1:50, BD PharmingenTM), CD8 (1:50, Ser-
otec), CD19 (1:50, BD PharmingenTM), MPO (1:50, Abcam,
Cambridge, MA) and platelet antibody (1:1000, Intercell,
Gaithersburg, MD). Briefly, the heart bases were directly
embedded in OCT and frozen at 220uC. Blocks were cut into
10 mm sections and fixed with chilled acetone in 220uC. To block
endogenous peroxidases, slides were immersed in 1% H2O2 in
methanol for two minutes at 40uC. Non-specific sites were blocked
using 1.5% serum from the secondary antibody-derived animal for
15 minutes at 40uC. Slides were then incubated with primary
antibodies for 15 minutes at 40uC, then for 15 minutes with
biotinylated secondary antibody, and then for 10 minutes with
ABC detector (Vector Labs) at 40uC. Hypersensitive response and
pathogenicity substrate-chromogen (Biomed) was used as the
chromogen, and hematoxylin (Accurate Chemical & Scientific
Corp., Westbury, NY) was used for counter-staining. Frozen slides
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were fixed with chilled acetone in 220uC. Non-specific sites were
blocked using 1.5% serum from the secondary antibody derived
animal for 20 minutes at RT. Slides were then incubated with
PECAM-1 primary antibody (1:50, BD PharmingenTM) at RT for
one hour and a rhodamine-conjugated goat-anti-rat secondary
antibody (15 mg/ml, Jackson ImmunoResearch, West Grove, PA)
at RT for 30 minutes. Slides were viewed and images were taken
using a Leica TCS SP5 laser scanning inverted confocal
microscope.
Immunostaining of targeted proteins was quantified in tissue
sections from TAC mice and their respective sham controls. For
each antibody, isotope-matched non reactive IgG served as the
negative control. The percentage of the vessel area occupied by
inflammatory cells was measured from digital images using
Metamorph software by personnel blinded to treatment. Perivas-
cular and interstitial fibrosis was measured from Masson’s
Trichrome and picrosirius red-stained slides. Vessel area was
quantified using Metamorph software and reported as external
elastic laminar.
Quantitative PCR
RNA samples were extracted from the apex of the heart (stored
in RNA later, 280uC) using TRIzol (Invitrogen, Grand Island,
NY) as previously described [31]. RNA concentration and quality
were tested using OD 260/280 ratio by Biomate3 (Thermo Electron
Corporation, Waltham, MA) and also by examining the product
on a 1% agarose gel. The cDNA synthesis was performed using
High-Capacity cDNA Archive kit (Applied Biosystems, Foster
City, CA), starting with 1 mg RNA in 20 ml reaction system.
Quantitative, real-time PCR was done using Taqman Universal
Master Mix and Assays-on Demand primers and probes (Applied
Biosystems) and the ABI 7500 system. 18S RNA was used as an
endogenous control. An embryo RNA standard was used as a
positive control. Results were expressed as mean fold changes of
gene expression relative to sham-operated C57Bl/6 mice or
control antibody-injected TAC mice using 22DDCT method [31].
Flow cytometry
Fifty ml blood was collected in 0.32% citrate and incubated with
anti-Mac-1 antibody (PE conjugated, BD PharmingenTM) at a
final concentration of 20 mg/ml, or rat IgG (PE conjugated,
Figure 1. TAC-induced LV pressure overload stimulates left coronary remodeling and dysfunction in wild-type C57BL/6 male mice.
A) Ratio of right/left (R/L) peak Doppler flow velocity in carotid arteries before and at indicated times after TAC (closed circle) or sham (open circle)
surgery. B) Representative images of Masson’s Trichrome stained left ventricle showing left coronary arteries five weeks after sham or TAC surgery.
(Top bar = 2323 mm; bottom bar = 230 mm). C) Impact of sham (open) and TAC (closed) surgery on coronary flow velocity in mice anesthetized with
1% (baseline conditions; circles) and 2.5% (hyperemic conditions; triangles) isoflurane. D) Coronary flow reserve (CFR), measured as the ratio of flow
velocity in mice anesthetized with 2.5% isoflurane to that observed in mice anesthetized with 1% isoflurane, declines in TAC (closed circle) but not
sham (open circle) mice, indicating vascular dysfunction.
doi:10.1371/journal.pone.0040196.g001
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Emfret, Eibelstadt, Germany) as an isotype control in the presence
of 1 mM RGDS peptide to prevent platelet aggregation. CD41 Ab
(FITC conjugated, BD PharmingenTM) was added to give a final
concentration of 20 mg/ml. To activate platelets, 150 mM PAR4
activating peptide (Anaspec, Fremont, CA) was added. After
15 minutes of incubation, 1 ml of Phosflow Lyse/Fix buffer
solution (BD Biosciences, San Jose, CA) was added to each sample.
Platelet-leukocyte aggregates were quantified using FACS caliber
flow cytometer (BD Biosciences).
To measure platelet activation by flow cytometry, blood was
collected into 0.32% citrate and diluted further in Tyrode’s Buffer
with 0.35% BSA and 1 mM MgCl2. The diluted blood was
incubated with 60 mg/ml FITC anti-fibrinogen (DAKO Corp.,
Carpinteria, CA) or 20 mg/ml FITC anti-P-selectin antibody (BD
Biosciences) and the indicated agonist, for 10 minutes in the dark.
The reaction was stopped by the addition of Tyrode’s buffer and
paraformaldehyde. Samples were quantified by flow cytometer by
gating on platelet populations identified by forward and side-
scatter properties.
Whole blood aggregation
Aggregation was studied in whole blood using a MultiplateH,
Platelet Function Analyzer (Dynabyte, Munich, Germany). 300 ml
of whole blood was diluted 1:1 with normal saline (0.91%) and
1 mM MgCl2 solution and incubated for 3 minutes at 37uC, prior
to the addition of 6.5 mM ADP. Aggregation units (AU) and the
area under the curve (AUC in AU * minutes) was calculated based
on measurements of electric impedance.
Mouse plasma collection
Mouse blood was collected into EDTA–coated tubes, immedi-
ately centrifuged at 2000 g for 10 minutes at RT, and plasma
stored at 280uC.
Mouse cardiac tissue extraction
The base of the LV was dissected (2 mm62 mm pieces) in
250 ml of PBS containing protease inhibitors (Pierce), homoge-
nized using Omni tissue homogenizer, and then sonicated for
10 seconds. Following centrifugation (14000 rpm for 15 minutes
at 4uC), approx 200 ml of supernatant was diluted with 200 ml PBS
containing protease inhibitors.
Luminex assay
Inflammatory cytokine/chemokine levels in mouse plasma and
extracts of cardiac tissue were measured by Luminex bead analyte
assay using Milliplex MAP Kit according to the manufacturer’s
instructions (Millipore Corp., Billerica, MA).
Culturing and treatment of myocardial fibroblasts
Primary myocardial fibroblasts were isolated from C57BL/6
male mice by mincing hearts in1 ml of dispase solution. After fully
mincing, 4 ml dispase solution was added, the sample placed at
37uC, and pipetted up and down at 15 minutes. After 30 minutes,
5 ml HBSS+ solution was added to neutralize the dispase. The cell
suspension was then centrifuged at 2200 rpm for eight minutes.
The cell pellet was saved and resuspended in plating medium (low
glucose DMEM+10% FBS+penicillin/streptomycin). Cells from
one heart were settled in one, six-well plate over night, washed the
next day, and added with fresh media. The attached myocardial
fibroblasts were cultured for seven to 10 days to reach a 70% to
80% confluence before treatment.
Washed platelets were isolated from ACD buffered C57BL/6
male mice blood. 1.56109 platelets were stimulated using 1 U/ml
of thrombin at 37uC for 10 minutes, then neutralized with 1 U/ml
hirudin. The suspension was then centrifuged at 3000 g at 4uC for
10 minutes and supernatant was collected. Myocardial fibroblasts
were treated with 1 ml/well of either platelet releasate or buffer
(both diluted 1:5 in medium with 0.1% FBS). Cells were harvested
at six hours or 24 hours, and RNA was isolated using RNeasy Plus
mini kit (Qiagen, Valencia, CA). The cDNA synthesis and
quantitative PCR were performed as described before.
Statistical analysis
All results were expressed as mean 6 standard error of the
mean (SEM). Statistical significance within strains was determined
using t-test or two-way ANOVA with multiple pair-wise compar-
isons, as appropriate. The Mann-Whitney test was used for
nonparametic analysis. Statistical analysis was performed using
Sigma-STAT software, version 3.5 (Systat Software, Inc., Chicago,
IL). A p-value of less than 0.05 was considered significant.
Results
TAC is accompanied by early pericoronary inflammation
Transverse aortic constriction (TAC) induces an acute and
persistent increase in proximal aortic and LV pressure, manifested
by an elevation in the ratio of the right to left carotid peak flow
velocity (Figure 1A). Through cellular and molecular events that
are not completely understood, LV pressure overload in mice
elicits significant perivascular and interstitial cardiac fibrosis at five
weeks post-surgery [27] (Figure 1B). As reported by Hartley and
colleagues [28–30], we observed a decline in coronary flow reserve
(CFR) after TAC, indicating dysfunction of the coronary arteries
(Figures 1C and 1D). In the present study, we investigated the
contribution of early perivascular inflammation to coronary artery
remodeling and perivascular fibrosis in the setting of pressure
overload. As early as one day post-surgery, inflammatory cells
accumulated along the left coronary arteries (Figure 2). Both
macrophages (CD68+; Figures 2A and 2B) and T-lymphocytes
(CD90.2+; Figures 2A and 2C) in the vessels increased by
approximately four-fold during the first week post-TAC. The
CD8 staining confirmed the presence of T cells. However, B cells
stained by CD19 were not detected after TAC (Figure 2A). The
expression of vascular cell adhesion molecule 1 (VCAM-1) and
myeloperoxidase (MPO) were also increased after TAC
(Figure 2A). The inflammatory infiltration in the left coronary
arteries was accompanied by a perturbation in the endothelium, as
evidenced by discontinuous platelet-endothelial cell adhesion
molecule-1 (PECAM-1, CD31) staining (Figure 3).
To provide insight into the underlying mechanisms for
inflammation and remodeling early after TAC we measured
RNA or protein levels of candidate cytokine mediators, such as
monocyte chemotactic protein-1 (MCP-1), intercellular adhesion
molecule-1 (ICAM-1), tumor necrosis factor-a (TNF-a), interleu-
kin-6 (IL-6), which were known to contribute in other hypertrophy
models [10–14]. We also measured levels of growth factor b-1
(TGFb-1) [32–35] and vascular endothelial growth factor (VEGF),
which have demonstrated roles in fibrosis and angiogenesis in the
setting of cardiac hypertrophy. Additionally, because our IHC
data indicated early T lymphocyte accumulation, we measured
RNA or protein levels of IL-1b, IL-10, and interferon-c(IFN-c) in
order to define the T lymphocyte subtypes involved. At seven days
after TAC, MCP-1 (Figure 4A) and VEGF (Figure 4B), increased
in cardiac tissue. Additionally, IL-10 mRNA expression increased
more than three-fold in the LV between three and seven days after
TAC (Figure 4C). In the first several days after TAC, there were
no significant changes in TNF-a, ICAM-1, TGFb-1 or IFN-c
Pressure Overload and Perivascular Inflammation
PLOS ONE | www.plosone.org 4 August 2012 | Volume 7 | Issue 8 | e40196
mRNA levels in LV (data not shown). Plasma cytokines, including
IL-1b, IL-10, VEGF, IFN-c,TNF-a, and MCP-1, also did not
appreciably change early after TAC, although a trend towards
higher plasma IL-6 level post-TAC was noted (data not shown).
Effects of thrombocytopenia on TAC-induced LV
remodeling
Platelets often contribute to perivascular inflammation [15,20–
26], and enhanced platelet activation is found in patients with
cardiac hypertrophy and heart failure [16,17]. Therefore, we
investigated the contribution of platelets to the inflammatory
response that accompanies TAC. At seven days after surgery,
platelet counts in whole blood were higher in TAC animals
(12996226/nl) than sham mice (8036191/nl; P,0.001). Pressure
overload led to platelet deposition along the damaged endothelial
layer at three and seven days after TAC surgery (Figure 5A). The
platelets appeared to accumulate in association with leukocytes,
including macrophages (Figure 5B). Systemic platelet activation
can be detected in settings of vascular inflammatory diseases, such
as atherosclerosis [36–39]. One measure of platelet activation is
the presence of circulating platelet-leukocyte aggregates in
systemic circulation. In blood collected at seven days after sham
surgery, 2563% of the leukocytes had attached platelets, whereas
3967% of the leukocytes had attached platelets in blood from
TAC mice (P= 0.106). Interestingly, at three and seven days after
surgery, agonist-induced platelet aggregation in whole blood and
platelet P-selectin expression were lower in TAC than in sham-
treated animals (data not shown), suggesting that the platelets
Figure 2. TAC elicits an early inflammatory response in wild-type (C57BL/6) male mice. A) Immunohistochemical staining of inflammatory
cells and adhesion molecules in LV sections from wild-type male mice subjected to sham or TAC surgery and sacrificed at different time points
(D =days). Positive staining is in red-brown (mag. 406; Bar = 70 mm T lymphocytes are indicated by CD90.2 and CD8; CD19 is a B lymphocyte marker.
VCAM is an endothelial inflammatory marker and myeloperoxidase (MPO) an enzyme stored and released by neutrophils and macrophages. B) and C)
Quantification of the accumulation of macrophage (CD68) and T lymphocyte (CD90.2), as measured by area of positive staining in and around the
coronary arteries, at different time points following sham (open circles) and TAC (closed circles) surgery. Values are presented as mean 6 sem. The
images are representative of those obtained in the following numbers. For macrophages: TAC day one, n = 5; TAC day three, n = 7; TAC day seven,
n = 9; sham day one, n = 3; sham day three, n = 4; sham day seven, n = 5. For lymphocytes: TAC day one, n = 7; TAC day three, n = 6; TAC day seven,
n = 6; sham day one, n = 4; sham day three; n = 5; sham day seven, n = 5. *P,0.05 versus same time point in sham.
doi:10.1371/journal.pone.0040196.g002
Figure 3. Endothelial disruption at three and seven days after
TAC surgery. Confocal (left and middle panel) and IHC (right panel)
images of PECAM (CD31) staining along the lumen of left coronary
arteries at three days after sham surgery (sham D3) and at three (TAC
D3) and seven days (TAC 7D) after TAC surgery. CD31 staining appears
continuous along the luminal side in sham mice and discontinuous
along similar vessels in TAC mice. Bar = 70 mm.
doi:10.1371/journal.pone.0040196.g003
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Figure 4. Upregulation of inflammatory markers after TAC in wild-type mice. Levels of MCP-1 (A) and VEGF (B) were measured in
homogenized LV at seven days after sham (n= 6) or TAC surgery (n = 8) by Luminex assay. Protein expression (pg/ml) in the homogenate is reported
for each individual mouse, and boxes indicated median and 95% CI. (C) RNA was isolated from LV apex at one to seven days after TAC (n = 3–7 per
time point). IL-10 mRNA levels were measured by qPCR and values normalized to the sham value at day one, which was set at 100% expression, and
presented as mean 6 SD. *P,0.05 versus sham.
doi:10.1371/journal.pone.0040196.g004
Figure 5. Platelet accumulation and effects on perivascular inflammation. A) Immunohistochemical staining for platelets three days after
TAC (mag. 406). B) Platelet deposition co-localized with macrophages in coronary arteries at seven days after TAC (TAC D7). Serial sections through
coronary arteries were stained with antibodies to platelets (top), CD68 (middle) and CD31 (bottom). (mag. 406; Bar = 70 mm). Area of positive
perivascular staining for C) macrophages (vessel number = n, anti-GPIba IgG n= 23, non-immune IgG n=18) and D) T lymphocytes (vessel
number = n, anti-GPIba IgG n= 26, non-immune IgG n= 18) three days after TAC. *P= 0.05. E) Expression of inflammation markers in LV apex at three
days post-TAC was measured by qPCR (mice number= n, anti-GPIba IgG n=13, non-immune IgG n= 10) presented as mean 6 SD.
doi:10.1371/journal.pone.0040196.g005
Pressure Overload and Perivascular Inflammation
PLOS ONE | www.plosone.org 6 August 2012 | Volume 7 | Issue 8 | e40196
remaining in circulation post-TAC may be less responsive to
agonists.
To identify a role for platelets in TAC-induced vascular
remodeling, thrombocytopenia was induced by treating mice with
a glycoprotein Iba (GPIba) antibody that promotes platelet
clearance through an Fc fragment-independent pathway [40].
Following anti-GPIba IgG treatment, the median platelet count of
70/nL (25–75% CI: 50–101/nL) was substantially lower than the
median platelet count of 1362/nL observed in mice treated with
non-immune IgG (25–75% CI: 1070–1567/nL; P,0.001). White
blood cell count was normal, with no lymphopenia noted after
administration of anti-GPIba IgG. The effect of antibody
treatment on platelet function was confirmed by measuring tail-
bleeding time. The median bleeding time was .600 seconds in
mice treated with anti- GPIba IgG (600–660 seconds; 25–75% CI)
and 70 seconds (55–77 seconds; 25–75% CI) in mice treated with
non-immune IgG (P,0.001). Depletion of platelets prior to TAC
did not significantly alter macrophage accumulation but reduced
the accumulation of T lymphocytes in the coronary arteries after
TAC (from a median of 524 mm2 to 122 mm2; P= 0.031,
Figures 5C and 5D). In association with lower T-cell accumulation
in thrombocytopenic mice, IL-10 levels in LV were 50% lower in
mice treated with anti-GPIba IgG (Figure 5E).
To determine the long-term consequences of platelet depletion
and resultant reductions in T-lymphocytes and IL-10 in the vessel
wall, we examined coronary arteries at five weeks after TAC. In
thrombocytopenic mice, the large coronary arteries contained
significantly more smooth muscle cell (SMC) a-actin, consistent
with an effect on vascular remodeling (Figures 6A and 6B). In
addition, mice treated with anti-GPIba IgG had a trend towards
an increase in perivascular fibrosis (Figure 6C). These findings
were not due to alterations in cardiac size or function since heart
weight to body weight ratio and left ventricular internal diameter
in diastole (LVIDd) posterior wall thickness (PWt), and fractional
shortening (FS) (as measured by echocardiography), were similar
in control and thrombocytopenic mice (data not shown).
In addition to recruiting inflammatory cells, platelets may
release mediators that directly affect cardiac fibroblasts and
thereby influence perivascular fibrosis. Therefore, the effect of
platelet releasate on cardiac fibroblasts was investigated. Releasate
was prepared from thrombin-activated platelets and incubated
with primary cultures of murine cardiac fibroblasts. Following six
hours of exposure to platelet releasate, expression of MMP9
mRNA significantly increased by 15.560.6-fold (Figure 7) and
remained elevated at 24 hours (Figure 7). Platelet releasate also
increased a-SMA expression at 24 hours. In addition, TGFb-1
signaling appeared to be enhanced, in that the downstream targets
bone morphogenic protein 7 (BMP7) and connective tissue growth
factor (CTGF) were 6.662.4 and 3.860.1-fold higher following
exposure to platelet releasate.
Absence of lymphocytes exaggerates left coronary
remodeling
Our results indicated that T (but not B), lymphocytes accrue in
the vessel wall as part of the inflammatory response after TAC and
that depletion of platelets reduced their perivascular accumulation.
To define the impact of lymphocytes on coronary remodeling we
used Rag12/2 mice. Rag1 encodes the recombination activation
gene 1 that catalyzes V(D)J recombination, an essential step for the
generation of immunoglobulins and T lymphocyte receptors. As a
consequence, Rag12/2 mice lack mature B and T lymphocytes
[41]. The absence of lymphocytes in Rag12/2 mice did not
significantly alter the number of macrophages that accumulated in
the coronary arteries seven days after TAC (data not shown). The
absence of lymphocytes also did not alter the development of LVH,
as HW: BW was not significantly different in wild-type and Rag12/
2mice at five weeks post-TAC (Table 1). Likewise, overall coronary
artery remodeling, as measured by the area of the vessel within the
external elastic lamina, was similar in wild-type and Rag12/2 mice
after TAC (Figures 8A and 8B). However, lumen area was 1.32-fold
smaller in Rag12/2 coronary arteries after TAC, with a concom-
itant increase in collagen content. Quantification of Masson’s
Trichrome (Figure 8C) and picrosirius red staining (Figure 8E)
indicated that Rag12/2 mice had less perivascular fibrosis
(Figure 8D) and collagen content (Figure 8F) at baseline but greater
levels after TAC than that observed in wild-type mice. Thus, the
fold increase in perivascular fibrosis (11-fold, P= 0.031, Figure 8D)
and collagen content (43-fold, P= 0.008, Figure 8F) was signifi-
cantly higher in Rag12/2 mice post-TAC. Interestingly, despite
these histological changes, the Rag12/2 mice demonstrated
preserved CFR after TAC. CFR was 1.8360.15 in wild-type mice
that underwent sham surgery (n= 7) and 1.7260.23 in sham-
Figure 6. Thrombocytopenia promotes coronary vessel remodeling and perivascular fibrosis after TAC. A) Representative images (mag.
406) and B) quantification of a-smooth muscle actin staining in coronary arteries of thrombocytopenic (anti-GPIba IgG treated) and control (non-
immune IgG injected) mice five weeks after TAC surgery (vessel number = n, anti-GPIba IgG n= 11, non-immune IgG n= 5). *P,0.05. C) Area of
pericoronary fibrosis thrombocytopenic and control mice five weeks after TAC (vessel number = n, anti-GPIba IgG n= 10, non-immune IgG n=5).
Fibrosis was identified by Masson’s Trichrome stain and reported as area mean 6 sem.
doi:10.1371/journal.pone.0040196.g006
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treated Rag12/2 mice (n= 3). Following TAC, CFR declined to
1.2260.31 in wild-type mice (n= 13; P,0.05). However, CFR was
not significantly different in sham and TAC Rag12/2 mice
(1.5760.16; n= 7), suggesting that despite the smaller lumen size
and greater collagen content, the function of the coronary arteries
after TACwas preserved in the absence of lymphocytes. At baseline,
in comparison to wild-type mice, Rag12/2 mice had reduced LV
function which did not decline further following TAC (Table 2).
IL-10 may play a protective role in LV remodeling
Platelets can influence the function of T-cells by eliciting the
release of IL-10 from dendritic cells [42]. The finding that
thrombocytopenia lowered both T-cell infiltration and IL-10 levels
after TAC suggested that platelets may be influencing T-cell-
mediated events in an IL-10-dependent manner in this model.
Therefore, we sought to determine if IL-10 deficiency recapitu-
lated aspects of the phenotype observed in thrombocytopenic or
lymphopenic mice. Cardiac hypertrophy, as assessed by HW: BW
ratio, was not significantly different in IL-102/2 and wild-type
mice after TAC (7.762.0 and 7.161.3, respectively, P= 0.596).
However, IL-102/2 LV displayed substantial perivascular fibrosis
as detected by Masson’s Trichrome staining (Figure 9A) with levels
(11,60062000 mm2, mean 6 sem; n= 5) similar to those observed
in thrombocytopenic and Rag12/2 mice post-TAC, and was
significantly higher than B6 mice. The IL-102/2 TAC mice also
displayed evidence of exaggerated remodeling as measured by
SMC a-actin-staining, with a similar level of B6 mice (Figure 9B).
Discussion
We previously reported that pressure overload in mice elicited
significant perivascular and interstitial cardiac fibrosis at five weeks
post-surgery [27]. As reported by Hartley and colleagues, we
observed impaired coronary artery function, as measured by CFR,
after TAC [28–30]. In the present study, we expanded our
findings by examining the contribution of early perivascular
inflammation to coronary artery remodeling in the setting of
pressure overload. A striking and rapid accumulation of platelets,
macrophages, and T lymphocytes occurred around the left
coronary vessels post-TAC. Quantification of coronary vessel size
revealed that TAC mice had a significant increase in vessel size as
compared to sham-operated animals. In parallel, perivascular
fibrosis formation significantly increased. Although the precise
mechanism(s) by which changes in flow may affect the coronary
remodeling after TAC are unknown, numerous studies have
shown that flow-induced changes in shear stress can contribute to
perivascular inflammatory responses in coronary atherosclerosis
and in-stent restenosis [43,44]. In particular, PECAM-1 (CD31)
serves as part of the mechanical sensor complex regulating flow-
induced vascular inflammation and remodeling [45–49]. In our
model, endothelial disturbance, as evidenced by discontinuous
PECAM staining, occurred within three days after TAC.
Therefore, we hypothesize that pressure overload in the left
ventricle alters coronary flow, shear stress, and endothelial
function, which subsequently triggers platelet deposition and
perivascular accumulation of inflammatory cells. The precise
Figure 7. The effects of platelet releasate on myocardial fibroblasts. qPCR was performed to detect the differences of mRNA expression in
cardiac fibroblasts exposed to platelet releasate (dark bars) or buffer (open bars) for six (left) or 24 (right) hours. The values were normalized to the
buffer-treatment group at the same time point, which was set at fold increase and presented as mean 6 SD.
doi:10.1371/journal.pone.0040196.g007
Table 1. Organ and body weight in WT and Rag12/2 mice five weeks after TAC or sham surgery.
Genotype Treatment n BW (g) HW:BW LiW:BW LuW:BW KiW:BW
WT sham 3 24.862.1 5.260.84 44.963.0 6.160.4 13.761.2
WT TAC 7 25.061.3 6.960.2# 41.865.4 6.660.5 14.160.7
Rag12/2 sham 3 29.761.5 5.660.4 52.661.7 5.160.2 12.761.0
Rag12/2 TAC 7 27.76 1.7 6.760.2* 48.761.1 5.560.2 12.660.5
Results are presented as mean 6 sd; BW=body weight, HW=heart weight, LW= liver weight, LuW= lung weight, KiW= kidney weight. Two-way ANOVA statistics show
significant differences in the ration of heart weight to body weight between TAC and sham groups in B6 and Rag12/2 mice.
#P,0.001,
*P,0.05 vs sham controls.
doi:10.1371/journal.pone.0040196.t001
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molecular mechanism(s) responsible for the changes are presently
not understood. Future studies will investigate whether PECAM-1
expression or phosphorylation is altered by flow changes resulting
from TAC.
The appearance of platelet positive staining on the luminal
surface of left coronary vessels and co-localization with leukocytes,
suggested a role for platelets in coronary artery remodeling in
response to pressure overload. Previous literature has reported that
platelets dynamically influence the immune system through
CD154 (CD40L) mediated interactions with CD40 on T and B
lymphocytes [50–52]. Moreover, platelets enhance IL-10 expres-
sion by immature dendritic cells, which in turn promote the
proliferation of naive T cells [42]. We report that pericoronary T
lymphocytes accumulation was significantly reduced in thrombo-
cytopenic mice, suggesting a potential role for platelets in T
lymphocytes recruitment, either through direct contact or
indirectly through mediators. Our immunodepletion protocol
resulted in thrombocytopenia for up to one week, supporting a role
for platelets in this time frame. Because platelet deposition and
lymphocyte accumulation appeared as early as 24 hours after
TAC (data not shown and Figure 2A), we are unable to establish
whether platelet deposition is the initiating event or whether it
occurs in response to inflammatory changes and serves to
perpetuate the inflammatory response.
Exposure to high shear stress enables platelets to elicit IL-10
production from dendritic cells [42]. The change in flow following
Table 2. Echocardiographic analysis of heart size and
function in WT and Rag12/2 mice five weeks after TAC or
sham surgery.
genotype treatment n FS (%)
WT sham 3 3961.8
WT TAC 7 25.361.2*
Rag12/2 sham 3 32.261.8#
Rag12/2 TAC 7 28.461.8
FS = fractional shortening;
*P,0.05;
#P,0.001 vs WT sham control.
doi:10.1371/journal.pone.0040196.t002
Figure 8. Enhanced TAC-induced coronary remodeling in the absence of lymphocytes. A) H&E staining (mag. 206) and B) measurement
of vessel area inside the external elastic laminar in wild-type (WT) and Rag12/2 male mice five weeks after sham or TAC surgery (TAC: WT n=10,
Rag12/2 n= 17. Sham: WT n= 9, Rag12/2 n=6). C) Masson’s Trichrome staining and D) quantification of pericoronary fibrosis formation in WT and
Rag12/2 male mice five weeks after surgery reported as area mean 6 sem (TAC: WT n=10, Rag12/2 n= 13. Sham: WT n=9, Rag12/2 n=6). E)
Picrosirius red staining and F) quantification of pericoronary collagen deposition in WT and Rag12/2 male mice five weeks after surgery reported as
area mean 6 sem (TAC: WT n=9, Rag12/2 n=19. Sham: WT n= 7, Rag12/2 n= 7). *P,0.05. Bar = 70 mm.
doi:10.1371/journal.pone.0040196.g008
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TAC may trigger a similar response from platelets and contribute
to IL-10 expression and T-cell accumulation, which would
account for lower levels of IL-10 and T cells in thrombocytopenic
animals. The subsequent increase in SMC a-actin in thrombocy-
topenic animals could reflect an impact of these events on either
the proliferative or inflammatory profile of SMC. Immune-
mediated thrombocytopenia is followed by reactive thrombocyto-
sis. Therefore, in the anti-GPIba IgG-treated mice, it is possible
that a subsequent increase in platelet count is influencing
subsequent events, although given the propensity for platelet
surfaces to passivate over time, this seems less likely than an effect
of the initial thrombocytopenia.
Previous reports have implicated T lymphocytes in hypertensive
cardiovascular diseases [53]. Our observations in Rag12/2 mice
additionally suggest a role for lymphocytes in influencing
remodeling by limiting neointima formation and perivascular
fibrosis following TAC. Interestingly, despite the increase in
fibrosis, CFR was improved in the absence of lymphocytes. These
effects are likely mediated largely by T cells, as we were unable to
detect changes in B-cell accumulation in cardiac tissue post-TAC.
In addition, at baseline, the collagen content in Rag12/2 mice was
lower, supporting a role for lymphocytes in extracellular matrix
dynamics under basal conditions. Others have reported lower
basal vascular superoxide levels in Rag12/2 mice [53]. Vascular
superoxide correlates with and may influence fibrotic remodeling,
and may underlie the differences in the perivascular collagen
content we observed in the sham-operated Rag12/2 mice.
The subsets of T cells involved in TAC-induced remodeling
responses are presently unknown. Subsets of T lymphocytes
appear to differentially influence pathological remodeling. For
example, whereas CD1d-positive natural killer cells seem to
promote the development of neointima after vascular injury in a
carotid collar model [54], CD4+CD25+ regulatory T cells adoptive
transfer not only reduces angiotensin-induced early infiltration of
inflammatory cells in cardiac tissue, but also blunts the subsequent
development of cardiac hypertrophy, fibrosis formation, and
arrhythmogenic potential [55]. Moreover, a balance between T
helper 1 (Th1) and Th2 cells has been proposed to contribute to
coronary and myocardial inflammation, and may be essential for
cardiac extracellular matrix remodeling [56–58]. In an immune
modulation mouse model, induction of Th1 responses led to
increased collagen deposition, more LV stiffness, and down-
regulation of MMP-9 and MMP-13 gene expression [57].
In the TAC model, we observed a significant increase in
expression of IL-10 in cardiac tissue between days one and seven
post-TAC. IL-10 is a Th2 cytokine produced by many cell types,
including macrophages and T helper 2 cells. IL-10 signals through
the JAK/STAT3 pathway to modulate the expression of certain
pro-inflammatory molecules and usually plays an important role in
anti-inflammatory responses. For example, IL-10 is able to
attenuate the NF-kB pathway through inhibition of IKK or NF-
kB nuclear translocation [59]. Also, IL-10 can suppress vascular
smooth muscle cell activation and proliferation and thereby
attenuate neointima formation [15,60,61]. Recently, Krishna-
murthy et al. reported that IL-10 treatment reduced macrophage
accumulation and inflammatory cytokine expression, leading to
attenuated LV remodeling after myocardial infarction [62]. In
keeping with these observations, bone marrow, mononuclear cell-
derived IL-10, attenuates T-cell infiltration and cardiac remodel-
ing after myocardial infarction, which prevents cardiac dysfunc-
tion [63]. In our model, increased expression of IL-10 parallels T
lymphocyte infiltration early after TAC and may serve to
attenuate the inflammatory responses and suppress SMC prolif-
eration. Indeed, lower IL-10 levels correlate with increased medial
hypertrophy in thrombocytopenic mice after TAC. Likewise, IL-
102/2 mice display normal cardiac hypertrophy, but exaggerated
vascular fibrotic remodeling post-TAC.
Figure 9. TAC-induced coronary remodeling in the absence of IL-10. A) Representative sections stained with Masson’s Trichrome (MT) and
visualized at 406mag. five weeks after sham or TAC surgery (left) and measurements of perivascular fibrosis area (sham n=5; TAC n= 5). B) SMC a-
actin staining five weeks after sham or TAC surgery (left) and measurements of vessel area occupied by SMC a-actin (right). *P,0.05. Bar = 70 mm.
doi:10.1371/journal.pone.0040196.g009
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The results presented above indicate that platelets may
influence coronary remodeling and perivascular fibrosis after
TAC through recruitment of T lymphocytes and stimulating IL-
10-dependent signaling. In addition, platelets may have direct
effects on coronary fibroblast function by releasing mediators that
phenotypically modify fibroblasts. Indeed, we found that platelet
releasate directly stimulates cardiac fibroblasts to increase the
MMP9 expression and upregulate TGFb-1 signaling. Platelets
contain large storage of TGFb-1 in their a-granules that could
potentially activate fibroblasts and increase MMP production.
Whether platelet-triggered MMP9 production attenuates or
otherwise affects fibrosis remains to be established.
In summary, perivascular inflammation proceeds and accom-
panies coronary remodeling in the setting of pressure overload.
Platelets, macrophages and lymphocytes accumulate along and
around the coronary arteries early after TAC, accompanied by up-
regulation of IL-10 expression in the myocardial tissue. Following
TAC, the vessels undergo positive remodeling that is accompanied
by extensive perivascular fibrosis (Figure 10). Surprisingly, both
platelets and lymphocytes appear to play a protective role in
minimizing remodeling and fibrosis. Our data are consistent with
a model in which platelets influence lymphocyte recruitment –
either by direct interaction or indirectly through stimulation of IL-
10 (and/or other mediators) – by recruited or resident cells. The
IL-10 may act to suppress ongoing inflammation and limit
perivascular fibrosis. Similar mechanisms may occur in settings of
hypertension and our model may have particular relevance to
hypertensive urgency, in which acute and dramatic elevations in
blood pressure may be associated with a disruption in endothelial
function and a pro-inflammatory state in coronary arteries. The
optimal strategy for minimizing coronary artery damage in the
setting of acute elevations in pressure remains to be determined.
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